Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
1R01AR044384-01
Application #
2083988
Study Section
Special Emphasis Panel (SRC (40))
Project Start
1996-05-05
Project End
2001-04-30
Budget Start
1996-05-05
Budget End
1997-04-30
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294

  Publications

Hida, Daisuke; Danielson, Ben T; Knudson, Cheryl B et al. (2015) CD44 knock-down in bovine and human chondrocytes results in release of bound HYAL2. Matrix Biol 48:42-54
Moreland, Larry W; O'Dell, James R (2002) Glucocorticoids and rheumatoid arthritis: back to the future? Arthritis Rheum 46:2553-63
Bridges Jr, S Louis; Jenq, Grace; Moran, Molly et al. (2002) Single-nucleotide polymorphisms in tumor necrosis factor receptor genes: definition of novel haplotypes and racial/ethnic differences. Arthritis Rheum 46:2045-50
Moreland, L W; Bucy, R P; Weinblatt, M E et al. (2002) Immune function in patients with rheumatoid arthritis treated with etanercept. Clin Immunol 103:13-21
Robinson, W H; Genovese, M C; Moreland, L W (2001) Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 44:1977-83
Moreland, L W (2001) Potential biologic agents for treating rheumatoid arthritis. Rheum Dis Clin North Am 27:445-91
Koopman, W J; Moreland, L W (1998) Rheumatoid arthritis: anticytokine therapies on the horizon. Ann Intern Med 128:231-3